Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
Olema Pharmaceuticals (OLMA)
- 10.700
- +0.070+0.66%
Trading Aug 17 15:31 ET
936.22MMarket Cap-5.05P/E (TTM)
10.950High10.510Low505.10KVolume10.610Open10.630Prev Close5.42MTurnover0.85%Turnover RatioLossP/E (Static)87.50MShares36.25952wk High2.17P/B636.68MFloat Cap5.36052wk Low--Dividend TTM59.50MShs Float60.270Historical High--Div Yield TTM4.14%Range %2.000Historical Low10.736Avg Price1Lot Size
About Olema Pharmaceuticals Company
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Company Profile
SymbolOLMA
Company NameOlema Pharmaceuticals
Listing DateNov 19, 2020
Issue Price19.00
ISINUS68062P1066
Founded2006
CEODr. Sean P. Bohen, M.D.,PhD
MarketNASDAQ
Employees131
Fiscal Year Ends12-31
Address780 Brannan Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-415-651-3316
Websitehttp://www.olema.com
Company Executives
- Name
- Position
- Salary
- Dr. Sean P. Bohen, M.D.,PhD
- Director, President and Chief Executive Officer
- 3.18M
- Shawnte M. Mitchell, J.D.
- Chief Legal Officer and Corporate Secretary
- 2.05M
- Dr. Naseem Zojwalla, M.D.
- Chief Medical Officer
- --
- Dr. David C. Myles, PhD
- Chief Scientific Officer
- --
- Jason O'Byrne
- Chief Financial Officer
- --
- Sasha Lu Austin
- Vice President, Finance and Controller
- --
- Ian T. Clark
- Chairman of the Board
- 145.69K
- Yi Larson
- Independent Director
- 125.91K
- Cynthia M. Butitta
- Independent Director
- 126.84K
- Scott Garland
- Independent Director
- 119.39K
- Andrew S. Rappaport
- Independent Director
- 121.44K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 118.19K
- Dr. Prakash Raman, PhD
- Independent Director
- --
- Dr. Graham Waley, M.D.,PhD
- Independent Director
- 114.69K
- Dr. Gorjan Hrustanovic, PhD
- Independent Director
- 116.19K
- Dr. Cyrus L. Harmon, PhD
- Independent Director
- 109.44K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm